OncoMed Pharmaceuticals, Inc.
OMED
OMED was delisted on the 22nd of April, 2019.
63 hedge funds and large institutions have $155M invested in OncoMed Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 10 reducing their positions, and 11 closing their positions.
190% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 10
73% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 11
15% more funds holding
Funds holding: 55 → 63 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
23% less capital invested
Capital invested by funds: $200M → $155M (-$45.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.3M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.19M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.43M |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.23M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCI
Columbus Circle Investors
|
-$10.9M |
| 2 |
CCM
Cupps Capital Management
Chicago,
Illinois
|
-$4.33M |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$4.05M |
| 4 |
Primecap Management
Pasadena,
California
|
-$1.83M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$1.68M |
OMED Hedge Fund Activity: Q2 2014 in Review
63 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in OncoMed Pharmaceuticals, Inc. (OMED) for Q2 2014, worth a combined $155M — down 23% from $200M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new OMED positions and 11 closed out — a net gain of 8 holders — while 29 added to existing stakes and 10 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $16.3M. The largest seller was Columbus Circle Investors, cutting an estimated $10.9M.
- 63 institutional investors held OncoMed Pharmaceuticals, Inc. (OMED) as of Q2 2014, up from 55 in Q1 2014.
- Funds reported $155M of OncoMed Pharmaceuticals, Inc. stock for Q2 2014, down 23% quarter-over-quarter.
- 19 funds opened new OncoMed Pharmaceuticals, Inc. positions in Q2 2014 and 11 closed out, a net change of +8 holders.
- The largest OncoMed Pharmaceuticals, Inc. buyer in Q2 2014 was Fidelity Investments, an estimated $16.3M added.
- The largest OncoMed Pharmaceuticals, Inc. seller in Q2 2014 was Columbus Circle Investors, an estimated $10.9M sold.
Based on aggregated 13F filings for Q2 2014.